The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy
Abstract
Abstract —Hepatocyte growth factor (HGF) exclusively stimulates the growth of endothelial cells without replication of vascular smooth muscle cells and acts as a survival factor against endothelial cell death. Therefore we hypothesized that a decrease in local vascular HGF might be related to the pathogenesis of peripheral arterial disease. We initially evaluated vascular HGF concentration in the vessels of patients with arteriosclerosis obliterans. Consistent with in vitro findings that hypoxia downregulated vascular HGF production, vascular HGF concentration in the diseased segments of vessels from patients with arteriosclerosis obliterans was significantly decreased as compared with disease-free segments from the same patients ( P <0.05), accompanied by a marked reduction in HGF mRNA. On the other hand, a novel therapeutic strategy for ischemic diseases that uses angiogenic growth factors to expedite and/or augment collateral artery development has recently been proposed. Thus in view of the decreased endogenous vascular HGF, rhHGF (500 μg/animal) was intra-arterially administered through the internal iliac artery of rabbits in which the femoral artery was excised to induce unilateral hind limb ischemia, to evaluate the angiogenic activity of HGF, which could potentially have a beneficial effect in hypoxia. Administration of rhHGF twice on days 10 and 12 after surgery produced significant augmentation of collateral vessel development on day 30 in the ischemic model as assessed by angiography ( P <0.01). Serial angiograms revealed progressive linear extension of collateral arteries from the origin stem artery to the distal point of the reconstituted parent vessel in HGF-treated animals. In addition, we examined the feasibility of intravenous administration of rhHGF in a moderate ischemia model. Importantly, intravenous administration of rhHGF also resulted in a significant increase in angiographic score as compared with vehicle ( P <0.01). Overall, a decrease in vascular HGF might be related to the pathogenesis of peripheral arterial disease. In the presence of decreased endogenous HGF, administration of rhHGF induced therapeutic angiogenesis in the rabbit ischemic hind limb model, as potential cytokine supplement therapy for peripheral arterial disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning and expression of human hepatocyte growth factor
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., & Shimizu, S. (1989) · Nature · doi:10.1038/342440a0 · Cited by 2,157
Self-citationRisau, W., & Flamme, I. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000445 · Cited by 1,406
Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., & Comoglio, P. M. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.629 · Cited by 1,337
Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.12.1114 · Cited by 1,098
Suggested standards for reports dealing with lower extremity ischemia
Rutherford, R. B., Flanigan, D. P., Gupta, S. K., Johnston, K. W., Karmody, A., Whittemore, A. D., Baker, J. D., Ernst, C. B., Jamieson, C., & Mehta, S. (1986) · Journal of Vascular Surgery · doi:10.1016/0741-5214(86)90326-5 · Cited by 1,081
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,036
Self-citationEmerging Multipotent Aspects of Hepatocyte Growth Factor
Matsumoto, K., & Nakamura, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021283 · Cited by 660
Self-citationBanai, S., Jaklitsch, M. T., Shou, M., Lazarous, D. F., Scheinowitz, M., Biro, S., Epstein, S. E., & Unger, E. F. (1994) · Circulation · doi:10.1161/01.cir.89.5.2183 · Cited by 596
The Epidemiology of Lower Extremity Amputations in Diabetic Individuals
Most, R. S., & Sinnock, P. (1983) · Diabetes Care · doi:10.2337/diacare.6.1.87 · Cited by 561
Salvage of Infarcted Myocardium by Angiogenic Action of Basic Fibroblast Growth Factor
Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C., et al. (1992) · Science · doi:10.1126/science.1382313 · Cited by 517
Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.97.4.381 · Cited by 445
Second European Consensus Document on chronic critical leg ischemia.
(1992) · PubMed · Cited by 440
Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and Regeneration
Matsumoto, K., & Nakamura, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7517 · Cited by 358
Self-citationMagnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis
Pearlman, J. D., Hibberd, M. G., Chuang, M. L., Harada, K., Lopez, J. J., Gladstone, S. R., Friedman, M., Sellke, F. W., & Simons, M. (1995) · Nature Medicine · doi:10.1038/nm1095-1085 · Cited by 326
Baffour, R., Berman, J., Garb, J. L., Rhee, S. W., Kaufman, J., & Friedmann, P. (1992) · Journal of Vascular Surgery · doi:10.1016/0741-5214(92)90106-i · Cited by 324
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
Fate of the patient with chronic leg ischaemia. A review article.
Dormandy, J., Mahir, M., Ascady, G., BALSANO, F., De Leeuw, P., Blombery, P. A., Bousser, M., Clément, D., Coffman, J. D., & Deutshinoff, A. (1989) · PubMed · Cited by 295
Nicosia, R. F., Nicosia, S. V., & Smith, M. (1994) · PubMed · Cited by 293
Naldini, L., Vigna, E., Bardelli, A., Follenzi, A., Galimi, F., & Comoglio, P. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.603 · Cited by 242
Vascular endothelial growth factor administration in chronic myocardial ischemia
Harada, K., Friedman, M., Lopez, J. J., Wang, S. Y., Li, J., Prasad, P. V., Pearlman, J. D., Edelman, E. R., Sellke, F. W., & Simons, M. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.5.h1791 · Cited by 240
Oncogenic conversion by regulatory changes in transcription factors
Lewin, B. (1991) · Cell · doi:10.1016/0092-8674(91)90640-k · Cited by 210
Isner, J. M., Walsh, K., Symes, J., Pieczek, A., Takeshita, S., Lowry, J., Rosenfield, K., Weir, L., Brogi, E., & Jurayj, D. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.8-959 · Cited by 165
Self-citationYo, Y., Morishita, R., Nakamura, S., Tomita, N., Yamamoto, K., Moriguchi, A., Matsumoto, K., Nakamura, T., Higaki, J., & Ogihara, T. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00092.x · Cited by 97
Self-citationSilvagno, F., Follenzi, A., Arese, M., Prat, M., Giraudo, E., Gaudino, G., Camussi, G., Comoglio, P. M., & Bussolino, F. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1857 · Cited by 92
Nakano, N., Morishita, R., Moriguchi, A., Nakamura, Y., Hayashi, S.-I., Aoki, M., Kida, I., Matsumoto, K., Nakamura, T., Higaki, J., et al. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.444 · Cited by 86
Self-citationMorishita, R., Higaki, J., Hayashi, S.-I., et al. (1997) · Diabetologia · doi:10.1007/s001250050787 · Cited by 82
Self-citationHayashi, S.-I., Morishita, R., Higaki, J., Aoki, M., Moriguchi, A., Kida, I., Yoshiki, S., Matsumoto, K., Nakamura, T., Kaneda, Y., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0440 · Cited by 81
Self-citationYo, Y., Morishita, R., Yamamoto, K., Tomita, N., Kida, I., Hayashi, S.-I., Moriguchi, A., Kato, S.-I., Matsumoto, K., Nakamura, T., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00726.x · Cited by 66
Self-citationCritical leg ischaemia: an appraisal of clinical definitions
Tyrrell, M. R., & Wolfe, J. H. N. (1993) · British journal of surgery · doi:10.1002/bjs.1800800214 · Cited by 63
Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
Besser, D., Bardelli, A., Didichenko, S. A., Thelen, M., Comoglio, P. M., Ponzetto, C., & Nagamine, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1200879 · Cited by 46
Cited by
NAKAMURA, T., & MIZUNO, S. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.588 · Cited by 547
Self-citationGene transfer as a tool to induce therapeutic vascular growth
Ylä-Herttuala, S., & Alitalo, K. (2003) · Nature Medicine · doi:10.1038/nm0603-694 · Cited by 404
Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N., & Gerritsen, M. E. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64058-8 · Cited by 396
Taniyama, Y., Tachibana, K., Hiraoka, K., Aoki, M., Yamamoto, S., Matsumoto, K., Nakamura, T., Ogihara, T., Kaneda, Y., & Morishita, R. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301678 · Cited by 394
Self-citationHepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
Matsumoto, K., & Nakamura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00717.x · Cited by 353
Self-citation
Metadata
- Authors
- Morishita, R., Nakamura, S., Hayashi, S.-I., Taniyama, Y., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Takeshita, S., Matsumoto, K., Nakamura, T., Higaki, J., & Ogihara, T.
- Venue
- Hypertension
- Published
- 1999-06
- Volume
- 33
- Issue
- 6
- Pages
- 1379-1384
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2143499157
- Cited by
- 267
- References
- 30
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.